Gene Therapies and Rare Diseases: Advancing Research with Humanized Models and AI, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, learn how to accelerate the R&D of effective gene therapies for rare diseases with a range of innovative AI-powered resources. Attendees will learn how analytic tools from the Rare Disease Data Center (RDDC) can give new insights on rare diseases. The featured speaker will discuss how Cyagen’s humanized model project provides clinically relevant genetic humanization models of rare disease for preclinical research, including ophthalmology and neurology applications. Attendees will learn how an AI-powered AAV design & virus packaging platform improves delivery and transduction performance for significantly accelerated gene therapy R&D.

It has become increasingly essential for researchers, biotechs and pharmaceutical companies developing rare disease therapies to implement AI tools that get results both quickly and cost-effectively — vastly reducing time to clinical trials.

The discovery and development of orphan drugs and gene therapies for rare diseases face many challenges, including: insufficient knowledge regarding the underlying disease mechanisms, the lack of clinically relevant humanized animal disease models, insufficient AAV vector productivity and targeted delivery in gene therapy development and more.

In light of the challenges faced with orphan drug development, there has been growing interest in leveraging bioinformatics and artificial intelligence (AI) tools for accelerating drug discovery. It has become increasingly essential for researchers, biotechs and pharmaceutical companies developing rare disease therapies to implement AI tools that get results both quickly and cost-effectively — vastly reducing time to clinical trials.

The Rare Disease Data Center (RDDC) provides interfaces for the interactive visualization and exploration of biomedical data alongside several gene diagnosis tools based on the sophisticated AI and machine learning models. The RDDC integrates all reported rare disease data and information, including: epidemiological data, disease-related gene profile, variants, phenotypes, drug developmental outlines and disease-associated mouse models.

Register for the webinar now and join Dr. Kugeng (KG) Huo, for a discussion on how to use the Rare Diseases Data Center (RDDC) resources and Cyagen’s one-stop CRO platform to accelerate the R&D of effective gene therapies for rare diseases.

Join Kugeng (KG) Huo, PhD, Senior Scientist, Cyagen Biosciences, for the live webinar on Friday, December 9, 2022, at 11am EST (5pm CET/EU-Central).

For more information, or to register for this event, visit Gene Therapies and Rare Diseases: Advancing Research with Humanized Models and AI.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Vera Kovacevic
Xtalks
+1 (416) 977-6555 x371
Email >
Visit website